Name: Eli Lilly & Co. (NYSE:LLY) | Common-Size Liabilities and Stockholders’ Equity
Creator: Stock Analysis on Net

Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

Eli Lilly & Co., common-size consolidated balance sheet: liabilities and stockholders’ equity

	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Short-term borrowings and current maturities of long-term debt	0.02%	3.82%	2.58%	8.24%	4.99%
Accounts payable	3.45%	3.58%	3.22%	3.14%	3.48%
Employee compensation	2.14%	2.33%	2.40%	2.22%	2.31%
Sales rebates and discounts	12.55%	12.56%	11.44%	9.93%	10.09%
Dividends payable	1.65%	1.71%	1.48%	1.31%	1.41%
Income taxes payable	1.06%	0.41%	0.92%	1.18%	0.31%
Other current liabilities	5.90%	5.57%	5.04%	6.30%	5.72%
Current liabilities	26.77%	29.97%	27.07%	32.32%	28.31%
Long-term debt, excluding current maturities	35.57%	35.17%	26.51%	22.10%	21.56%
Accrued retirement benefits	8.78%	9.41%	6.63%	7.81%	6.32%
Long-term income taxes payable	8.23%	9.18%	8.48%	8.40%	1.78%
Other noncurrent liabilities	3.66%	3.82%	3.31%	3.06%	5.19%
Deferred tax liabilities	4.50%	5.57%	3.14%	0.38%	0.56%
Other liabilities	60.74%	63.16%	48.08%	41.74%	35.40%
Total liabilities	87.51%	93.13%	75.15%	74.06%	63.72%
Common stock, no par value	1.28%	1.52%	1.51%	1.53%	1.77%
Additional paid-in capital	14.54%	17.02%	14.99%	12.93%	14.54%
Retained earnings	16.79%	12.52%	25.95%	30.89%	41.35%
Employee benefit trust	-6.46%	-7.67%	-6.86%	-6.70%	-7.76%
Accumulated other comprehensive loss	-13.93%	-16.61%	-13.05%	-12.71%	-13.59%
Cost of common stock in treasury	-0.12%	-0.15%	-0.16%	-0.17%	-0.21%
Total Eli Lilly and Company shareholders’ equity	12.10%	6.64%	22.38%	25.77%	36.10%
Noncontrolling interests	0.39%	0.23%	2.46%	0.17%	0.19%
Total equity	12.49%	6.87%	24.85%	25.94%	36.28%
Total liabilities and equity	100.00%	100.00%	100.00%	100.00%	100.00%

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21).

Balance sheet item	Description	The company
Current liabilities	Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.	Eli Lilly & Co.’s current liabilities as a percentage of total liabilities and equity increased from 2018 to 2019 but then decreased significantly from 2019 to 2020.
Other liabilities	Amount of obligation due after one year or beyond the normal operating cycle, if longer.	Eli Lilly & Co.’s other liabilities as a percentage of total liabilities and equity increased from 2018 to 2019 but then slightly decreased from 2019 to 2020.
Total liabilities	Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.	Eli Lilly & Co.’s total liabilities as a percentage of total liabilities and equity increased from 2018 to 2019 but then slightly decreased from 2019 to 2020.
Total Eli Lilly and Company shareholders’ equity	Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.	Eli Lilly & Co.’s total Eli Lilly and Company shareholders’ equity as a percentage of total liabilities and equity decreased from 2018 to 2019 but then slightly increased from 2019 to 2020.